Eligibility for Bevacizumab as an Independent Prognostic Factor for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer: A Retrospective Cohort Study

BACKGROUND: Bevacizumab requires some unique eligibility criteria, such as absence of hemoptysis and major blood vessel invasion by the tumor. The prognostic impact of these bevacizumab-specific criteria has not been evaluated. METHODS: Patients with stage IIIB/IV, non-squamous non-small cell lung c...

Descripción completa

Detalles Bibliográficos
Autores principales: Takagi, Yusuke, Toriihara, Akira, Nakahara, Yoshiro, Yomota, Makiko, Okuma, Yusuke, Hosomi, Yukio, Shibuya, Masahiko, Okamura, Tatsuru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608561/
https://www.ncbi.nlm.nih.gov/pubmed/23555751
http://dx.doi.org/10.1371/journal.pone.0059700

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3608561/
https://www.ncbi.nlm.nih.gov/pubmed/23555751
http://dx.doi.org/10.1371/journal.pone.0059700

Ejemplares similares